tiprankstipranks
Merck & Co. Buy Rating: Strong Market Position and Growth Potential Driven by Keytruda and Promising Pipeline
PremiumRatingsMerck & Co. Buy Rating: Strong Market Position and Growth Potential Driven by Keytruda and Promising Pipeline
6d ago
Positive Outlook for Merck & Co. Driven by Winrevair’s Success and Favorable Trial Results
Premium
Ratings
Positive Outlook for Merck & Co. Driven by Winrevair’s Success and Favorable Trial Results
6d ago
Eli Lilly’s (NYSE:LLY) Future Takes Aim at Big Problems in Plain Sight
Premium
Market News
Eli Lilly’s (NYSE:LLY) Future Takes Aim at Big Problems in Plain Sight
10d ago
Merck receives European Commission approval for WELIREG in two indications
PremiumThe FlyMerck receives European Commission approval for WELIREG in two indications
12d ago
Deutsche downgrades Merck ahead of Keytruda 2028 expiration
Premium
The Fly
Deutsche downgrades Merck ahead of Keytruda 2028 expiration
12d ago
Merck downgraded to Hold from Buy at Deutsche Bank
Premium
The Fly
Merck downgraded to Hold from Buy at Deutsche Bank
12d ago
Neuphoria Therapeutics to receive $15M payment from Merck
PremiumThe FlyNeuphoria Therapeutics to receive $15M payment from Merck
18d ago
Merck price target lowered to $115 from $122 at Guggenheim
Premium
The Fly
Merck price target lowered to $115 from $122 at Guggenheim
18d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100